Pink eye, also known as conjunctivitis, is a common and highly contagious eye infection characterized by inflammation of the conjunctiva – the thin, clear tissue that lines the inside of the eyelid and covers the whites of the eyes. This condition earns its name due to the telltale symptom it presents: reddish or pink discoloration in one or both eyes. Pink eye can be caused by several factors including bacterial or viral infections, allergies, irritants like smoke or chemicals, and even certain sexually transmitted diseases. Regardless of its origins, pink eye typically manifests with uncomfortable symptoms such as itching, burning sensations, excessive tearing, or discharge which may lead to crusting around the eyes. While proper hygiene practices such as handwashing and avoiding touching your face can help prevent this ailment from spreading further among individuals in close proximity – particularly in places like schools or offices where transmission is swift – timely medical intervention remains crucial to alleviate discomfort and prevent prolonged recuperation periods associated with this common ocular affliction.
1.
New policy review highlights the importance of health-related quality of life in advanced cancer
2.
New protocols, according to a study, allow many patients to safely return home one day after lung cancer surgery.
3.
Study identifies new target for obesity-related breast cancer
4.
Novel Agent Effective for Cancer Wasting Disorder
5.
The response of bipolar patients to lithium may be predicted by ancestry.
1.
Unexplained Weight Loss: Revealing Occult Cancers and Paraneoplastic Syndromes
2.
Targeted Approaches to Breast Cancer Liver Metastases: Surgery, Ablation, and Survival Insights
3.
Integrated Updates in Oncology for Specialists
4.
Pediatric Advances in Mapping Hematopoietic Development During Childhood
5.
The Importance of Balanced Potassium Levels in Maintaining Good Health
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Rates of CR/CRi and MRD Negativity in Iontuzumab-Treated Patients
2.
CDK4/6 Inhibitors Redefining Treatment for HR+/HER2- aBC In Post-Menopausal Women- A Panel Discussion
3.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part I
4.
Current Scenario of Cancer- An Overview of The Incidence of Cancer in Men
5.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Important Points to Know
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation